Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

SomaLogic Inc (SomaLogic), a subsidiary of Standard BioTools Inc, is a protein biomarker discovery and clinical diagnostics companys. Its activities include affinity-reagent development, multiplex protein profiling, biomarker research, data analysis, and support for translational and clinical research. Its products include the SomaScan Assay, SomaScan Panels, Single SOMAmer Reagents, SomaSignal Tests, KREX technology and it offers services such as assay services, data consulting, and bioinformatics software. It markets its products under the brands SomaScan, SOMAmer, SomaSignal, DataDelve, and KREX. The company serves pharmaceutical, biotechnology, academic, government, and life sciences researchers studying oncology, neurology, cardiometabolic conditions, infectious diseases, immunology, and other biological and therapeutic areas. SomaLogic is headquartered in Boulder, Colorado, the US.

Gain a 360-degree view of SomaLogic Inc and make more informed decisions for your business Gain a 360-degree view of SomaLogic Inc and make more informed decisions for your business Register your interest
Headquarters United States of America

Address 2945 Wilderness Place, Boulder, Colorado, 80301


Telephone 1 303 6259000

No of Employees 250

Industry Medical Equipment

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

SomaLogic Inc premium industry data and analytics

50+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

15+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on SomaLogic Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Single SOMAmer Reagents Pre-Analytical Variation DataDelve
Software: SomaSignal Tests SomaSignal
SomaScan Menu SomaScan Assay Services SomaScan
XYZ XYZ XYZ
XYZ XYZ XYZ
XYZ XYZ XYZ
Understand SomaLogic Inc portfolio and identify potential areas for collaboration Understand SomaLogic Inc portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Ownership Changes In January, the company was acquired by Illumina, Inc, a biotechnology company.
2024 Acquisitions/Mergers/Takeovers In January, SomaLogic merged with Standard BioTools Inc.
2023 Contracts/Agreements In September, the company extended its agreement with Novo Nordisk to expand its use of the SomaScan proteomics platform in drug research and development.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters SomaLogic Inc ARK Diagnostics Inc Alfa Wassermann Diagnostic Technologies, LLC Quotient Biodiagnostics Inc
Headquarters United States of America United States of America United States of America United States of America
City Boulder Fremont West Caldwell Newtown Square
State/Province Colorado California New Jersey Pennsylvania
No. of Employees 250 - - -
Entity Type Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into SomaLogic Inc key executives to enhance your sales strategy Gain insight into SomaLogic Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?